Impact of bleeding event for new Cancer diagnosis in patients with antiplatelet therapy after percutaneous coronary intervention.

[1]  C. Cannon,et al.  Common Pathophysiology in Cancer, Atrial Fibrillation, Atherosclerosis, and Thrombosis , 2021, JACC. CardioOncology.

[2]  Weichao Huang,et al.  Bleeding risks with novel oral anticoagulants especially rivaroxaban versus aspirin: a meta-analysis , 2021, Thrombosis Journal.

[3]  T. Luedde,et al.  Heart failure is associated with an increased incidence of cancer diagnoses , 2021, ESC heart failure.

[4]  D. Levy,et al.  Cardiovascular Risk Factors Are Associated With Future Cancer , 2021, JACC. CardioOncology.

[5]  B. Ibáñez,et al.  New Cancer Diagnosis After Bleeding in Anticoagulated Patients With Atrial Fibrillation , 2020, Journal of the American Heart Association.

[6]  N. Bragazzi,et al.  Global, regional, and national burden of ischaemic heart disease and its attributable risk factors, 1990–2017: results from the Global Burden of Disease Study 2017 , 2020, European heart journal. Quality of care & clinical outcomes.

[7]  J. Saver,et al.  Major bleeding risk with non‐vitamin K antagonist oral anticoagulant vs. aspirin in heart failure: network meta‐analysis , 2020, ESC heart failure.

[8]  A. Brandes,et al.  Hematuria and urinary tract cancers in patients with atrial fibrillation treated with oral anticoagulants. , 2020, European heart journal. Cardiovascular pharmacotherapy.

[9]  F. Otsuka,et al.  JCS 2020 Guideline Focused Update on Antithrombotic Therapy in Patients With Coronary Artery Disease. , 2020, Circulation journal : official journal of the Japanese Circulation Society.

[10]  A. Brandes,et al.  Gastrointestinal bleeding and the risk of colorectal cancer in anticoagulated patients with atrial fibrillation. , 2020, European heart journal.

[11]  U. Zeymer,et al.  Burden of Coronary Artery Disease and Peripheral Artery Disease: A Literature Review , 2019, Cardiovascular therapeutics.

[12]  M. Toyofuku,et al.  Application of the Academic Research Consortium High Bleeding Risk Criteria in an All-Comers Registry of Percutaneous Coronary Intervention. , 2019, Circulation. Cardiovascular interventions.

[13]  Deepak L. Bhatt,et al.  Bleeding and New Cancer Diagnosis in Patients with Atherosclerosis. , 2019, Circulation.

[14]  M. Price,et al.  Defining High Bleeding Risk in Patients Undergoing Percutaneous Coronary Intervention , 2019, Circulation.

[15]  D. Singer,et al.  Association of Intracranial Hemorrhage Risk With Non–Vitamin K Antagonist Oral Anticoagulant Use vs Aspirin Use: A Systematic Review and Meta-analysis , 2018, JAMA neurology.

[16]  C. Maack,et al.  Linking Heart Failure to Cancer: Background Evidence and Research Perspectives , 2018, Circulation.

[17]  Takeshi Kimura,et al.  Influence of a history of cancer on long-term cardiovascular outcomes after coronary stent implantation (an Observation from Coronary Revascularization Demonstrating Outcome Study-Kyoto Registry Cohort-2) , 2018, European heart journal. Quality of care & clinical outcomes.

[18]  P. Kolh,et al.  [2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS.] , 2018, Kardiologia polska.

[19]  Volkmar Falk,et al.  2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure , 2016, Revista espanola de cardiologia.

[20]  A. Blaes,et al.  Shared Risk Factors in Cardiovascular Disease and Cancer , 2016, Circulation.

[21]  B. Lacey,et al.  Epidemiology of Atherosclerosis and the Potential to Reduce the Global Burden of Atherothrombotic Disease. , 2016, Circulation research.

[22]  J. Cerhan,et al.  Heart Failure After Myocardial Infarction Is Associated With Increased Risk of Cancer. , 2014, Journal of the American College of Cardiology.

[23]  Peter L Duffy,et al.  Incidence, Predictors, and Impact of Post-Discharge Bleeding After Percutaneous Coronary Intervention. , 2015, Journal of the American College of Cardiology.

[24]  Y. Takeishi,et al.  Impact of peripheral artery disease on prognosis in hospitalized heart failure patients. , 2015, Circulation journal : official journal of the Japanese Circulation Society.

[25]  M. Brueckmann,et al.  Anticoagulant-related gastrointestinal bleeding—could this facilitate early detection of benign or malignant gastrointestinal lesions? , 2014, Annals of medicine.

[26]  Mary G. George,et al.  An Updated Definition of Stroke for the 21st Century: A Statement for Healthcare Professionals From the American Heart Association/American Stroke Association , 2013, Stroke.

[27]  David J Cohen,et al.  Association between bleeding events and in-hospital mortality after percutaneous coronary intervention. , 2013, JAMA.

[28]  Douglas G Altman,et al.  The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) Statement: guidelines for reporting observational studies. , 2014, International journal of surgery.

[29]  T. Sellers,et al.  Epidemiology — identifying the causes and preventability of cancer? , 2006, Nature Reviews Cancer.

[30]  S. Larsson,et al.  Diabetes mellitus and risk of colorectal cancer: a meta-analysis. , 2005, Journal of the National Cancer Institute.

[31]  M. Glade.  Food, nutrition, and the prevention of cancer: a global perspective. American Institute for Cancer Research/World Cancer Research Fund, American Institute for Cancer Research, 1997. , 1999, Nutrition.

[32]  H. Mcintosh.  Risk factors for cardiovascular disease and death: a clinical perspective. , 1989, Journal of the American College of Cardiology.

[33]  W. Kannel,et al.  The natural history of congestive heart failure: the Framingham study. , 1971, The New England journal of medicine.

[34]  Rickham Pp.  Human Experimentation: Code of Ethics of the World Medical Association (Declaration of Helsinki). , 1964, Canadian Medical Association journal.